Drug intelligence / Profile preview

obacunone

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Obacunone is a natural limonoid triterpenoid found in various citrus fruits and medicinal plants, notably Dictamnus dasycarpus and Phellodendron amurense. It is recognized for its multiple pharmacological properties, including antioxidant, anti-inflammatory, antifungal, antitumor, anti-fibrotic, and potential metabolic disease-modulating effects. Obacunone acts as a potent agonist of NRF2 (Nuclear factor erythroid 2-related factor 2), a regulator of cellular antioxidant responses, and has also been identified as a histone deacetylase 1 inhibitor with downstream suppression of p38 MAPK signaling. The compound’s mechanisms are multi-target in nature, conferring cytoprotection from oxidative stress, inhibition of inflammation, reduction of fibrosis, and potential suppression of certain tumors. Obacunone is under preclinical or early development for a range of indications, including infections (antifungal and antiviral), acute lung injury, fibrotic diseases, metabolic disorders such as hypercholesterolemia and osteoporosis, and cancer[1][3][4][6][7].

Other names
CasimirolideObacunoic acid eta-lactoneOBACUNONCHEBI:7713
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on obacunone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on obacunone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call